Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults [Phase 1]

View source ↗

Summary

A completed Phase 1 study assessing the safety and tolerability of NoNO-42 in healthy adults as a first-in-human trial intended for the treatment of acute ische…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NoNO-42

Snippet

Sponsor: NoNO Inc. | Conditions: First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke | Phase 1 | Status: COMPLETED